Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Bushen Hugu Decoction in the Treatment of Malignant Tumor Bone Metastases

Table 3

The network topology parameters of the top 8 components of BHD, based on BHD compounds, BM targets, and pathway network.

Mol ID	Mark	Component	Degree	Betweenness centrality	Closeness centrality
MOL000098	A3	Quercetin	71	0.27068666	0.57086614
MOL000422	A2	Kaempferol	27	0.06990185	0.44207317
MOL001978	DR13	Aureusidin	14	0.01494905	0.39459459
MOL000006	DR9	Luteolin	38	0.06739532	0.45886076
MOL000359	A1	Beta-sitosterol	11	0.01825399	0.40055249
MOL011604	EC13	Syringetin	11	0.00904134	0.38770053
MOL009091	DR10	Xanthogalenol	5	0.00086333	0.35194175
MOL000449	B2	Stigmasterol	4	0.00564496	0.36616162